Zimmer Biomet Holdings Inc (ZBH)
110.22
+1.82
(+1.68%)
USD |
NYSE |
Nov 22, 16:00
110.30
+0.08
(+0.07%)
After-Hours: 20:00
Zimmer Biomet Holdings Cash from Financing (Quarterly): -101.90M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -101.90M |
| June 30, 2024 | -91.90M |
| March 31, 2024 | -50.10M |
| December 31, 2023 | -251.40M |
| September 30, 2023 | -196.00M |
| June 30, 2023 | -109.40M |
| March 31, 2023 | -206.70M |
| December 31, 2022 | -313.40M |
| September 30, 2022 | -193.90M |
| June 30, 2022 | -146.00M |
| March 31, 2022 | -190.50M |
| December 31, 2021 | -655.80M |
| September 30, 2021 | -426.10M |
| June 30, 2021 | -28.30M |
| March 31, 2021 | -195.80M |
| December 31, 2020 | -286.30M |
| September 30, 2020 | -42.60M |
| June 30, 2020 | -1.586B |
| March 31, 2020 | 1.493B |
| December 31, 2019 | -182.70M |
| September 30, 2019 | -298.40M |
| June 30, 2019 | -163.60M |
| March 31, 2019 | -135.20M |
| December 31, 2018 | -275.50M |
| September 30, 2018 | -297.70M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.571B |
| March 31, 2018 | 841.80M |
| December 31, 2017 | -232.90M |
| September 30, 2017 | -320.70M |
| June 30, 2017 | -913.00M |
| March 31, 2017 | 256.10M |
| December 31, 2016 | -309.10M |
| September 30, 2016 | 519.20M |
| June 30, 2016 | -120.40M |
| March 31, 2016 | -832.90M |
| December 31, 2015 | -538.40M |
| September 30, 2015 | -144.20M |
| June 30, 2015 | 220.70M |
| March 31, 2015 | 7.569B |
| December 31, 2014 | -263.10M |
| September 30, 2014 | -15.90M |
| June 30, 2014 | -0.40M |
| March 31, 2014 | -290.70M |
| December 31, 2013 | -122.20M |
| September 30, 2013 | 60.30M |
| June 30, 2013 | 47.10M |
| March 31, 2013 | -452.50M |
| December 31, 2012 | -58.10M |
| September 30, 2012 | -116.30M |
| June 30, 2012 | -133.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.586B
Minimum
Jun 2020
1.493B
Maximum
Mar 2020
-188.08M
Average
-192.20M
Median
Cash from Financing (Quarterly) Benchmarks
| Stryker Corp | 2.653B |
| Boston Scientific Corp | 7.00M |
| NeuroOne Medical Technologies Corp | 1.560M |
| SINTX Technologies Inc | 2.858M |
| Nutriband Inc | -0.0051M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 395.70M |
| Cash from Investing (Quarterly) | -154.90M |
| Free Cash Flow | 1.259B |
| Free Cash Flow Per Share (Quarterly) | 1.816 |
| Free Cash Flow to Equity (Quarterly) | -369.20M |
| Free Cash Flow to Firm (Quarterly) | 427.36M |
| Free Cash Flow Yield | 5.54% |